All Work

Chris Lange

Why InVivo Therapeutics Soared

InVivo Therapeutics saw its shares surge by over 25% Monday on a pivotal announcement from its Inspire study.

Chris Lange · 11 years ago

Is This the Start of the Final Implosion at Celldex?

Celldex Therapeutics Inc. (NASDAQ: CLDX) got burned in Monday’s regular trading session and ultimately saw its shares fall by over 50%. The reasoning behind this? The independent Data Safety and Monitoring Board (DSMB) has…

Chris Lange · 11 years ago

Top 6 Earnings for the Week Ahead

24/7 Wall St. has put together a preview of Dollar General, Urban Outfitters and some other major companies reporting their quarterly results this coming week.

Chris Lange · 11 years ago

5 Companies That Destroyed Shareholders Last Week

Although stocks are beginning to make a comeback at this time, there are still those that are caught in the downturn slowing this recovery and punishing their shareholders.

Chris Lange · 11 years ago

Why Oppenheimer Is Downgrading Qualcomm Now

Its stock appears cheap, and Qualcomm boasts a strong balance sheet and solid capital return. However one key analyst sees continued structural challenges to the company's core business.

Chris Lange · 11 years ago

Why H&R Block Whiffed on Earnings

H&R Block reported disappointing third-quarter financial results after the markets closed on Thursday.

Chris Lange · 11 years ago

Why Ambarella Earnings Are Not Enough

Ambarella reported better-than-expected fiscal fourth-quarter financial results after the markets closed on Thursday.

Chris Lange · 11 years ago

Disney Cruise Line Adds 2 New Ships

Walt Disney has announced that it is adding a couple additional ships to its fleet. The new ships will be completed in 2021 and 2023.

Chris Lange · 11 years ago